Preview: United Therapeutics's Earnings

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2025-07-30. Here's what investors need to know before the announcement.

Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $6.87.

The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Overview of Past Earnings

In the previous earnings release, the company beat EPS by $0.10, leading to a 3.05% drop in the share price the following trading session.

Here's a look at United Therapeutics's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

6.53

6.31

6.42

6.40

EPS Actual

6.63

6.19

6.39

5.85

Price Change %

-3.0%

1.0%

3.0%

5.0%

United Therapeutics Share Price Analysis

Shares of United Therapeutics were trading at $298.14 as of July 28. Over the last 52-week period, shares are down 4.04%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Opinions on United Therapeutics

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on United Therapeutics.

The consensus rating for United Therapeutics is Neutral, based on 9 analyst ratings. With an average one-year price target of $356.33, there's a potential 19.52% upside.

Comparing Ratings with Competitors

In ...